Literature DB >> 19410196

Melanoma of the small intestine.

Marko Lens1, Veronique Bataille, Zoran Krivokapic.   

Abstract

Intestinal melanomas can be primary tumours or metastases of cutaneous, ocular, or anal melanomas. Primary intestinal melanoma is extremely rare, whereas metastatic melanoma of the small bowel is common because of the tendency for cutaneous melanoma to metastasise to the gastrointestinal tract. Because distinguishing between primary and metastatic intestinal melanoma can be difficult, the main features of each are discussed, and the diagnostic images used to detect intestinal melanoma are assessed. Routine barium examinations and CT have limited sensitivity, but PET imaging can improve detection of melanoma metastases to the small bowel. Although various treatment strategies have been tried in patients with intestinal melanoma, surgical removal of intestinal metastases is the treatment of choice in patients with resectable tumours. No systemic therapy improves survival in patients with melanoma metastatic to the intestines; thus, the prognosis for these patients is poor. Patients with primary melanoma of the small intestine have a worse prognosis than do patients with metastases of cutaneous melanoma.

Entities:  

Mesh:

Year:  2009        PMID: 19410196     DOI: 10.1016/S1470-2045(09)70036-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  57 in total

Review 1.  Mucosal melanoma: pathogenesis, clinical behavior, and management.

Authors:  Michael A Postow; Omid Hamid; Richard D Carvajal
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

2.  Intestinal metastasis from non-small-cell lung cancer initially detected by ¹⁸F-fluorodeoxyglucose positron emission tomography.

Authors:  Hiroaki Akamatsu; Asuka Tsuya; Kyoichi Kaira; Yukiko Nakamura; Tateaki Naito; Haruyasu Murakami; Toshiaki Takahashi; Masahiro Endo; Nobuyuki Yamamoto
Journal:  Jpn J Radiol       Date:  2010-11-27       Impact factor: 2.374

3.  Primary malignant melanoma of the small intestine: a report of 2 cases and a review of the literature.

Authors:  Kwan Mo Yang; Chan Wook Kim; So-Woon Kim; Jong Lyul Lee; Yong Sik Yoon; In Ja Park; Seok-Byung Lim; Chang Sik Yu; Jin Cheon Kim
Journal:  Ann Surg Treat Res       Date:  2018-04-30       Impact factor: 1.859

Review 4.  Primary small bowel melanoma. A case report and a review of the literature.

Authors:  K G Spiridakis; E E Polichronaki; E E Sfakianakis; M E Flamourakis; T H Margetousakis; A S Xekalou; G K Lianeris; E S Giannikaki; M S Christodoulakis
Journal:  G Chir       Date:  2015 May-Jun

5.  Duodenal and gallbladder metastasis of regressive melanoma: a case report and review of the literature.

Authors:  Hamza Ettahri; Fadwa Elomrani; Mustapha Elkabous; Mouna Rimani; Saber Boutayeb; Hind Mrabti; Hassan Errihani
Journal:  J Gastrointest Oncol       Date:  2015-10

Review 6.  Capsule endoscopy for management of small bowel melanoma-is it time yet?

Authors:  Emilia Prakoso; Warwick S Selby
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-10

Review 7.  Recurrent intussusception as initial manifestation of primary intestinal melanoma: Case report and literature review.

Authors:  Konstantinos Kouladouros; Daniel Gärtner; Steffen Münch; Mario Paul; Michael R Schön
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

8.  Small Bowel Obstruction in a Surgically Naïve Abdomen.

Authors:  Rohit Gupta; SreyRam Kuy
Journal:  Fed Pract       Date:  2020-03

9.  Imaging of gastrointestinal melanoma metastases: Correlation with surgery and histopathology of resected specimen.

Authors:  Ahmed E Othman; Thomas K Eigentler; Georg Bier; Christina Pfannenberg; Hans Bösmüller; Christian Thiel; Claus Garbe; Konstantin Nikolaou; Bernhard Klumpp
Journal:  Eur Radiol       Date:  2016-10-17       Impact factor: 5.315

Review 10.  Utility of positron emission tomography/CT in the evaluation of small bowel pathology.

Authors:  C G Cronin; J Scott; A Kambadakone; O A Catalano; D Sahani; M A Blake; S McDermott
Journal:  Br J Radiol       Date:  2012-09       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.